Unique ID issued by UMIN | UMIN000011901 |
---|---|
Receipt number | R000013903 |
Scientific Title | Study of the effect of tea on lipid metabolism, and creation of health foods processed from tea |
Date of disclosure of the study information | 2013/09/29 |
Last modified on | 2016/05/26 14:23:00 |
Study of the effect of tea on lipid
metabolism, and creation of health foods processed from tea
Study of the effect of tea on lipid
metabolism, and creation of health foods processed from tea
Study of the effect of tea on lipid
metabolism, and creation of health foods processed from tea
Study of the effect of tea on lipid
metabolism, and creation of health foods processed from tea
Japan |
dyslipidemia
Endocrinology and Metabolism |
Others
NO
To assess the effects of adding O-Methylated
EGCG to EGCG on biomarkers of lifestyle-related diseases in subjects prone to dyslipidemia
Safety,Efficacy
1) LDL-cholesterol
2) Total cholesterol
1) body weight, waist, blood pressure
2) Serum total cholesterol, MDA-LDL,
triglycerides
3) FPG, HbA1c, glycated albumin, insulin
4) high sensitive C reactive protein, catechin sensing molecule
5) antioxidant action in vivo
6) proinflammatory cytokine
7) AST, ALT, gamma-GTP
8) Serum iron, ferritin
9) adiponectin
10) urinalysis
11) diet survey
Interventional
Parallel
Randomized
Double blind -all involved are blinded
Placebo
3
Treatment
Food |
Take 3 g of barley tea extracts powder
dissolved in 200 ml of water three times
a day (total of 600 ml, the amount of
catechins and O-methylated EGCG are 0
mg and 0 mg, respectively) for 12 weeks.
Take 3 g of Yabukita green tea extracts
powder dissolved in 200 ml of water three
times a day (total of 600 ml, the amount
of catechins and O-methylated EGCG
are 600 mg and 0 mg, respectively) for 12
weeks.
Take 3 g of Benifuuki green tea extracts
powder dissolved in 200 ml of water three
times a day (total of 600 ml, the amount
of catechins and O-methylated EGCG
are 600 mg and 40 mg, respectively) for
12 weeks.
20 | years-old | <= |
80 | years-old | >= |
Male and Female
From 20 years old to 80 years old and meets
the followings;
1.LDL-Cholesterol: 120mg/dl or more
2.Body mass index: 25kg/m^2 or more
1) Individuals with a medical record of heart failure or cardiac infarction.
2) Individuals judged to have atrial fibrillation,
irregular Heart Beat, hepatic damage, kidney damage, cerebrovascular accident,
rheumatism, diabetes mellitus, lipid disorder and/or anemia.
3) Individuals with a medical record of allergy to food and drug.
4) Pregnant women, or women with intending
to become pregnant, and lactating women.
5) Individuals judged by the doctor to be
unsuitable.
150
1st name | |
Middle name | |
Last name | Toshiaki Hanafusa |
Osaka Medical College
Department of Internal Medicine (1)
2-7 Daigaku-machi, Takatsuki City, Osaka
072-683-1221
hanafusa@poh.osaka-med.ac.jp
1st name | |
Middle name | |
Last name | Hisashi Imbe |
Osaka Medical College
Department of Internal Medicine (1)
2-7 Daigaku-machi, Takatsuki City, Osaka
072-683-1221
in1297@poh.osaka-med.ac.jp
Department of Internal Medicine(1),Osaka
Medical College
National Agriculture and Food Research
Organization
NO
2013 | Year | 09 | Month | 29 | Day |
Published
http://www.sciencedirect.com/science/article/pii/S1756464616301189
Completed
2013 | Year | 09 | Month | 02 | Day |
2013 | Year | 10 | Month | 09 | Day |
2014 | Year | 05 | Month | 31 | Day |
2014 | Year | 10 | Month | 29 | Day |
2013 | Year | 09 | Month | 28 | Day |
2016 | Year | 05 | Month | 26 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000013903